Slide 1 Slide 2 Heart Disease and Stroke Statistics 2010 Update Slide 3 Questions on statistics? mailto:[email protected] on statistics? mailto:[email protected]…

1. An evaluation of NHS Health Checks in community pharmacy; changes in cardiovascular risk factors over one year in patients aged 40-74 SJ Butterworth SC Willis P Higginson…

Slide 1 VBWG New Frontiers in CVD Risk Management: Optimizing Outcomes in Patients with Multiple Cardiovascular Risks Slide 2 VBWG US population at high risk AHA. Heart Disease…

Slide 1 ... a KAISER PERMANENTE Innovation IndiGO: Tailoring Guidelines to Individuals David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,…

Slide 1 Cardiovascular Disease Risk Factor Profiles of HIV-infected Clients: Findings from a pilot program to integrate CVD screening into HIV services at a secondary health…

CVD risk estimation and prevention: An overview of SIGN 97 Dr. Rose Rosario GPST3 Annual prevalence of CVD 4.2% men 3% women Cardiovascular Disease (CVD) includesâ¦. Cerebrovascular…

Clinical Biochemistry FAQ for GP Trainees Dr Mourad Labib Consultant Chemical Pathologist DGOH NHS Foundation Trust July 2009 Plan Common scenarios How best to investigate…

Slide 1 Cardiovascular Disease Risk Factor Profiles of HIV-infected Clients: Findings from a pilot program to integrate CVD screening into HIV services at a secondary health…

Slide 1 ... a KAISER PERMANENTE Innovation IndiGO: Tailoring Guidelines to Individuals David M Eddy MD PhD Founder and Chief Medical Officer Emeritus Archimedes San Francisco,…

CV Update â Guidelines & Debates Royal Pharmaceutical Society, Great Britain Barnet â 27/01/09 Dr Ameet Bakhai, FRCP â Cardiologist, Clinical Trials, Health Economics…